Diphenylcyclopropenone (DPCP)

DRUG3 trials

Sponsors

Rockefeller University, Ain Shams University, University of Alabama at Birmingham

Conditions

MelanomaNeoplasm MetastasisSkin DiseasesVitiligo

Early Phase 1

Trem-1 and Ultraviolet Radiation-induced Immune Suppression

Active, not recruitingNCT05020496

University of Alabama at BirminghamSkin Diseases

Start: 2022-03-21End: 2027-10-01Target: 70Updated: 2026-07-20

Phase 1

Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)

CompletedNCT01711684

Rockefeller UniversityMelanoma, Neoplasm Metastasis

Start: 2012-10-16End: 2015-06-22Updated: 2017-11-29

Phase 4

Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo

CompletedNCT04775979

Ain Shams UniversityVitiligo

Start: 2021-01-17End: 2021-08-30Updated: 2023-04-11